期刊文献+
共找到443篇文章
< 1 2 23 >
每页显示 20 50 100
抗IL-13单抗抑制上呼吸道杯状细胞增生缓解急性声门下喉炎的疗效及分子机制研究
1
作者 万思远 林志星 +1 位作者 廖薇薇 李乐辉 《国际检验医学杂志》 2025年第2期168-174,共7页
目的探讨抗白细胞介素(IL)-13单抗通过缓解杯状细胞化生及增生在急性声门下喉炎治疗中的作用及其分子机制。方法采集海南医学院第一附属医院收治的33例临床急性声门下喉炎患儿的外周血标本,根据Westley哮喉评分将患儿分为轻度组(Mild gr... 目的探讨抗白细胞介素(IL)-13单抗通过缓解杯状细胞化生及增生在急性声门下喉炎治疗中的作用及其分子机制。方法采集海南医学院第一附属医院收治的33例临床急性声门下喉炎患儿的外周血标本,根据Westley哮喉评分将患儿分为轻度组(Mild group)和中-重度组(Moderate-Severe group)。体外在气/液界面(ALI)培养正常人支气管上皮细胞(NHBE细胞),细胞实验分组:Group-1(对照组,NHBE细胞维持培养)、Group-2(纤毛细胞诱导组)、Group-3(IL-13处理组)、Group-4(IL-13+抗IL-13单抗处理组)。采用酶联免疫吸附试验(ELISA)测定外周血血清或细胞培养上清液炎症因子IL-10、干扰素γ(IFN-γ)和IL-13水平。采用免疫印迹(Western blot)法测定杯状细胞分化标志物麦芽凝集素(WGA)和纤毛细胞分化标志物乙酰化-α-微管蛋白(AAT)的表达水平,以及磷酸化(p-)胞外信号调节蛋白激酶1/2(ERK1/2)和ERK1/2的表达水平,采用光学显微镜测量细胞直径。在体动物实验中,将30只雌性C57BL/6J小鼠随机分为Control组、Model组[使用卵清蛋白(OVA)+脂多糖(LPS)诱导哮喘小鼠模型]和Model+anti-IL-13 antibody组(鼻滴法给予Model组小鼠抗IL-13单抗治疗),每组10只。结果与Mild group相比,Moderate-Severe group外周血血清IL-10、IFN-γ和IL-13水平均升高(P<0.05)。与Group-1细胞相比,Group-2 AAT表达水平上调(P<0.05);Group-3 WGA表达水平上调(P<0.05),IL-10、IFN-γ和IL-13水平升高(P<0.05),杯状细胞直径增大(P<0.05),p-ERK1/2水平上调(P<0.05);与Group-3相比,Group-4 WGA表达水平下调(P<0.05),IL-10、IFN-γ和IL-13水平降低(P<0.05),杯状细胞直径减小(P<0.05),p-ERK1/2水平下调(P<0.05)。4组细胞ERK1/2表达水平差异无统计学意义(P>0.05)。在体动物实验结果显示,与Control组小鼠相比,Model组小鼠支气管炎症评分升高(P<0.05);与Model组相比,Model+anti-IL-13 antibody组小鼠支气管炎症评分降低(P<0.05)。结论抗IL-13单抗可抑制气道杯状细胞化生和增生,或许可用于缓解急性声门下喉炎。 展开更多
关键词 急性声门下喉炎 杯状细胞 白细胞介素-13 抗IL-13单抗
下载PDF
绞股蓝总皂苷对人肾上腺皮质癌SW-13细胞增殖及凋亡蛋白Caspase-8表达的影响 被引量:6
2
作者 刘丽 罗佐杰 卢杰 《广西医学》 CAS 2015年第6期801-803,809,共4页
目的探讨绞股蓝总皂苷(Gyp)体外干预对人肾上腺皮质癌(ACC)SW-13细胞增殖及其含半胱氨酸的天冬氨酸蛋白水解酶-8(Caspase-8)表达的影响。方法采用MTT法检测不同浓度的Gyp对SW-13细胞增殖的影响;普通显微镜下观察细胞形态学改变;实时荧... 目的探讨绞股蓝总皂苷(Gyp)体外干预对人肾上腺皮质癌(ACC)SW-13细胞增殖及其含半胱氨酸的天冬氨酸蛋白水解酶-8(Caspase-8)表达的影响。方法采用MTT法检测不同浓度的Gyp对SW-13细胞增殖的影响;普通显微镜下观察细胞形态学改变;实时荧光定量PCR检测Gyp干预后Caspase-8表达的变化。结果 Gyp对SW-13细胞增殖产生明显地抑制作用,且呈时间和浓度依赖性;光镜下观察,Gyp干预后SW-13细胞凋亡特征更明显;实时荧光定量PCR结果显示,Gyp干预后SW-13细胞Caspase-8 mRNA表达明显上调(P<0.01)。结论 Gyp可显著抑制人ACC SW-13细胞的增殖,其作用机制可能为通过上调Caspase-8 mRNA的表达来实现。 展开更多
关键词 绞股蓝总皂苷 肾上腺皮质癌 sw-13 细胞 含半胱氨酸的天冬氨酸蛋白水解酶-8
下载PDF
姜黄素干预肾上腺皮质癌SW-13细胞的miRNA调控机制 被引量:2
3
作者 黄雪梅 匡雅琪 +2 位作者 刘雨平 林媛媛 罗佐杰 《广西医学》 CAS 2022年第15期1758-1762,共5页
目的 探讨姜黄素干预肾上腺皮质癌SW-13细胞的miRNA调控机制。方法 将肾上腺皮质癌SW-13细胞分为对照组和姜黄素干预组,分别加入基础培养基2 mL、50μmol/L姜黄素溶液2 mL,干预24 h后提取总RNA用于小RNA文库构建和测序。将获得的序列进... 目的 探讨姜黄素干预肾上腺皮质癌SW-13细胞的miRNA调控机制。方法 将肾上腺皮质癌SW-13细胞分为对照组和姜黄素干预组,分别加入基础培养基2 mL、50μmol/L姜黄素溶液2 mL,干预24 h后提取总RNA用于小RNA文库构建和测序。将获得的序列进行miRNA注释和新miRNA预测后,筛选差异性表达的miRNA;对差异性表达的miRNA进行靶基因预测,对靶基因进行功能和通路富集分析。使用实时荧光定量PCR鉴定部分差异性表达miRNA的表达量。结果 共筛选出44个差异性表达的miRNA,包括21个表达上调的miRNA和23个表达下调的miRNA,其中预测有靶基因且有功能的miRNA共9个。功能富集分析结果显示,靶基因主要富集在细胞增殖、细胞迁移、细胞分化和凋亡等生物学过程;通路富集分析结果显示,靶基因主要富集在癌症途径、丝裂原活化蛋白激酶信号通路、内质网应激信号通路、细胞周期和凋亡途径等。实时荧光定量PCR结果提示,miR-184、miR-490-3p、miR-766-3p、miR-200b-3p、miR-200c-3p和miR-3622a-5p的表达量与小RNA测序数据结果基本一致。结论 姜黄素可能通过miR-184、miR-490-3p、miR-766-3p、miR-200c-3p、miR-3622a-5p等miRNA参与调控癌症途径、丝裂原活化蛋白激酶信号通路、内质网应激信号通路、细胞周期和凋亡途径等信号通路,以抑制细胞增殖、迁移、分化和凋亡,从而发挥抗肾上腺皮质癌的作用。 展开更多
关键词 肾上腺皮质癌 姜黄素 sw-13细胞 微小RNA 小RNA测序
下载PDF
氯硝柳胺对肾上腺皮质癌SW-13细胞增殖和凋亡的影响 被引量:1
4
作者 王敏捷 王尉 +2 位作者 朱沂 赵旭 胡卫列 《广东医学》 CAS 北大核心 2017年第1期76-82,共7页
目的研究氯硝柳胺对人肾上腺皮质癌SW-13细胞株细胞增殖、细胞周期、细胞凋亡和细胞迁移力、侵袭力的影响。方法通过体外培养SW-13细胞,采用CCK8法和i CELLigence实时无标记细胞增殖监测仪检测不同浓度氯硝柳胺对细胞增殖的影响;设对照... 目的研究氯硝柳胺对人肾上腺皮质癌SW-13细胞株细胞增殖、细胞周期、细胞凋亡和细胞迁移力、侵袭力的影响。方法通过体外培养SW-13细胞,采用CCK8法和i CELLigence实时无标记细胞增殖监测仪检测不同浓度氯硝柳胺对细胞增殖的影响;设对照组和氯硝柳胺组,流式细胞技术检测氯硝柳胺作用后SW-13细胞周期的变化,AO/EB染色法和Annexin V/PI染色流式细胞技术测定细胞凋亡率的变化,Transwell实验和细胞划痕实验检测细胞侵袭、迁移能力的变化,Western blot(WB)法检测β-catenin/LRP6表达的变化。结果不同浓度的氯硝柳胺分别作用SW-13细胞24、48、72、96、120 h后,呈时间和浓度依赖性抑制SW-13细胞增殖(F=157.93,P<0.001);流式细胞仪周期检测结果显示24、48、72 h后,与对照组相比氯硝柳胺组将SW-13细胞周期阻滞在G0/G1期(P=0.001、0.005、0.008);AO/EB染色法和Annexin V/PI染色法结果均显示氯硝柳胺组的凋亡率与对照组相比明显升高(P<0.001);Transwell实验结果示氯硝柳胺组SW-13细胞的侵袭力降低(P<0.001),细胞划痕实验结果显示氯硝柳胺组SW-13细胞的迁移能力下降(P=0.002),WB结果示氯硝柳胺组SW-13细胞β-catenin/LRP6的表达明显降低(P<0.001)。结论氯硝柳胺抑制人肾上腺皮质癌SW-13细胞增殖,阻滞细胞周期,抑制侵袭及迁移能力,促进细胞凋亡;可能与其抑制Wnt/β-catenin信号通路有关。 展开更多
关键词 氯硝柳胺 肾上腺皮质癌 sw-13 细胞增殖 细胞周期 细胞凋亡
下载PDF
羟喜树碱对人肾上腺皮质癌SW-13细胞凋亡的影响
5
作者 张劼 吴峰萍 +2 位作者 罗佐杰 梁杏欢 文静 《广西医科大学学报》 CAS 2014年第2期173-176,共4页
目的:研究羟喜树碱对人肾上腺皮质癌SW-13细胞生长抑制和凋亡作用的影响。方法:采用CCK8检测不同浓度羟喜树碱对SW-13细胞增殖的影响;流式细胞仪测定药物作用前后的细胞凋亡情况。结果:不同浓度的羟喜树碱分别作用24,48,72h后,SW-13细... 目的:研究羟喜树碱对人肾上腺皮质癌SW-13细胞生长抑制和凋亡作用的影响。方法:采用CCK8检测不同浓度羟喜树碱对SW-13细胞增殖的影响;流式细胞仪测定药物作用前后的细胞凋亡情况。结果:不同浓度的羟喜树碱分别作用24,48,72h后,SW-13细胞的生长增殖均受到明显抑制(P<0.01),并呈时间和浓度依赖性;流式细胞术显示SW-13细胞凋亡率随羟喜树碱浓度的增加而升高。结论:羟喜树碱可以显著抑制人肾上腺皮质癌SW-13细胞生长,促进其凋亡。 展开更多
关键词 羟喜树碱 人肾上腺皮质癌sw-13细胞 凋亡
下载PDF
羟喜树碱对人肾上腺皮质癌SW-13细胞生长增殖的影响 被引量:1
6
作者 吴峰萍 张劼 +2 位作者 罗佐杰 文静 梁杏欢 《广西医学》 CAS 2013年第10期1273-1274,1287,共3页
目的观察羟喜树碱对人肾上腺皮质癌SW-13细胞生长增殖的影响。方法体外培养人肾上腺皮质癌SW-13细胞,随机分为干预组和对照组,干预组加入羟喜树碱使其终浓度为0.8μg/ml,对照组不加羟喜树碱,分别培养48 h后,采用台盼蓝拒染法观察羟喜树... 目的观察羟喜树碱对人肾上腺皮质癌SW-13细胞生长增殖的影响。方法体外培养人肾上腺皮质癌SW-13细胞,随机分为干预组和对照组,干预组加入羟喜树碱使其终浓度为0.8μg/ml,对照组不加羟喜树碱,分别培养48 h后,采用台盼蓝拒染法观察羟喜树碱对SW-13细胞生长增殖的影响。结果光镜下可见干预组SW-13细胞数减少,死亡细胞数较多,干预组活细胞率明显低于对照组(P<0.05)。结论羟喜树碱可能具有抑制人肾上腺皮质癌SW-13细胞增殖并促进其死亡的作用。 展开更多
关键词 肾上腺皮质癌 羟喜树碱 人肾上腺皮质癌sw-13细胞 台盼蓝拒染法
下载PDF
乳腺癌患者病理特征与Bcl-2、CXCL13、PAX8表达情况的关系分析 被引量:1
7
作者 王洋 刘伟 +2 位作者 韩晓东 马娜 秦蕊 《检验医学与临床》 CAS 2024年第10期1431-1435,共5页
目的分析乳腺癌患者病理特征与B细胞淋巴瘤/白血病-2基因(Bcl-2)、趋化因子配体13(CXCL13)、配对盒基因8抗体(PAX8)表达情况的关系。方法收集2021年1月至2023年1月该院收治的160例乳腺癌患者临床资料。采用免疫组化法对其癌组织与癌旁组... 目的分析乳腺癌患者病理特征与B细胞淋巴瘤/白血病-2基因(Bcl-2)、趋化因子配体13(CXCL13)、配对盒基因8抗体(PAX8)表达情况的关系。方法收集2021年1月至2023年1月该院收治的160例乳腺癌患者临床资料。采用免疫组化法对其癌组织与癌旁组织Bcl-2、CXCL13、PAX8表达情况进行检测,并分析3项指标与患者病理特征的关系。结果与癌旁组织比较,癌组织Bcl-2、CXCL13、PAX8阳性率更高,差异有统计学意义(P<0.05)。与雌激素受体(ER)阴性、肿瘤最大径≥3 cm、孕激素受体(PR)阴性患者比较,ER阳性、肿瘤最大径<3 cm、PR阳性患者中Bcl-2高表达占比更高,差异有统计学意义(P<0.05);与无淋巴结转移、Ⅰ~Ⅱ期患者比较,淋巴结转移、Ⅲ~Ⅳ期患者中CXCL13高表达占比更高,差异有统计学意义(P<0.05);与Ⅰ~Ⅱ期、高/中分化、无淋巴结转移患者比较,Ⅲ~Ⅳ期、低分化、有淋巴结转移患者中PAX8高表达占比更高,差异有统计学意义(P<0.05)。ER、PR表达情况与Bcl-2表达情况呈正相关(P<0.05),肿瘤最大径与Bcl-2表达情况呈负相关(P<0.05);临床分期、淋巴结转移情况与CXCL13、PAX8表达情况呈正相关(P<0.05);分化程度与PAX8表达情况呈负相关(P<0.05)。结论乳腺癌患者Bcl-2、CXCL13、PAX8表达情况对疾病的发生和发展具有明显影响,有望成为评估乳腺癌患者病情严重程度的标志物。 展开更多
关键词 乳腺癌 B细胞淋巴瘤/白血病-2 趋化因子配体13 配对盒基因8抗体 临床病理
下载PDF
血清胸腺活化调节趋化因子、CXC亚家族趋化因子13与弥漫大B细胞淋巴瘤患者化疗疗效和预后的关系研究
8
作者 孙国锋 索晓慧 +5 位作者 刘洪峰 贺冠强 陈莉 常伟 李俊东 毛丹 《检验医学与临床》 CAS 2024年第21期3105-3110,共6页
目的探讨血清胸腺活化调节趋化因子(TARC)、CXC亚家族趋化因子13(CXCL13)与弥漫大B细胞淋巴瘤(DLBCL)患者化疗疗效和预后的关系。方法选取2017年1月至2020年6月该院收治的285例DLBCL患者(DLBCL组)及同期健康体检者160例(对照组)作为研... 目的探讨血清胸腺活化调节趋化因子(TARC)、CXC亚家族趋化因子13(CXCL13)与弥漫大B细胞淋巴瘤(DLBCL)患者化疗疗效和预后的关系。方法选取2017年1月至2020年6月该院收治的285例DLBCL患者(DLBCL组)及同期健康体检者160例(对照组)作为研究对象,DLBCL患者接受利妥昔单抗+环磷酰胺+多柔比星+长春新碱+泼尼松(R-CHOP)相关化疗方案,根据化疗效果分为有效组和无效组。比较DLBCL组与对照组、有效组与无效组血清TARC、CXCL13水平;随访统计DLBCL患者3年总生存期(OS)及无进展生存期(PFS),采用Logistic回归分析DLBCL患者预后及疾病进展的影响因素,并构建回归预测模型,采用受试者工作特征(ROC)曲线分析其预测评估效能。采用Kaplan-Meier生存曲线分析不同水平血清TARC、CXCL13与DLBCL患者3年OS及PFS的关系。结果DLBCL组治疗前血清TARC、CXCL13水平高于对照组(P<0.05)。DLBCL患者化疗有效率为85.26%,无效组治疗前血清TARC、CXCL13水平高于有效组(P<0.05)。多因素Logistic分析结果显示,Ann Arbor分期Ⅲ/Ⅳ期、TARC高表达及CXCL13高表达均是DLBCL患者预后的独立危险因素(P<0.05)。乳酸脱氢酶水平升高、TARC高表达及CXCL13高表达均是DLBCL患者疾病进展的独立危险因素(P<0.05)。以上述影响因素构建回归预测模型,ROC曲线分析显示,预测模型预测预后的曲线下面积(AUC)为0.874,预测疾病进展的AUC为0.911。TARC低表达患者的3年OS、PFS优于高表达患者(P<0.05),CXCL13低表达患者的3年OS、PFS优于高表达患者(P<0.05)。结论DLBCL患者血清TARC、CXCL13水平异常升高,血清TARC、CXCL13低表达的DLBCL患者具有更好的化疗效果及预后。包括血清TARC、CXCL13在内的多因子预测模型对DLBCL患者预后具有较高的评估效能。 展开更多
关键词 弥漫大B细胞淋巴瘤 胸腺活化调节趋化因子 CXC亚家族趋化因子13 化疗疗效 预后
下载PDF
血清sCD40L、ADAMTS13与老年髋部骨折患者术后下肢深静脉血栓形成的关系
9
作者 付广宇 周长明 +1 位作者 刘建民 李岩 《国际检验医学杂志》 CAS 2024年第24期2951-2955,共5页
目的 探讨血清可溶性细胞表面分化抗原40配体(sCD40L)、血管性血友病因子裂解蛋白酶13(ADAMTS13)水平与老年髋部骨折患者术后下肢深静脉血栓(DVT)形成的关系。方法 选取2022年6月至2023年6月在该院就诊的192例老年髋部骨折患者,根据其... 目的 探讨血清可溶性细胞表面分化抗原40配体(sCD40L)、血管性血友病因子裂解蛋白酶13(ADAMTS13)水平与老年髋部骨折患者术后下肢深静脉血栓(DVT)形成的关系。方法 选取2022年6月至2023年6月在该院就诊的192例老年髋部骨折患者,根据其术后是否发生下肢DVT分为非DVT组(120例)和DVT组(72例)。酶联免疫吸附试验检测各组血清sCD40L、ADAMTS13水平;Pearson法分析患者血清sCD40L与ADAMTS13水平的相关性;多因素Logistic回归模型分析影响老年髋部骨折患者术后发生下肢DVT的因素;受试者工作特征(ROC)曲线评估血清sCD40L、ADAMTS13水平对老年髋部骨折患者术后发生下肢DVT的预测价值。结果 两组高脂血症占比及骨折至开始手术时间比较,差异有统计学意义(P<0.05)。与非DVT组比较,DVT组血清sCD40L水平升高(P<0.05),ADAMTS13水平降低(P<0.05);Pearson法分析结果显示,患者血清sCD40L水平与ADAMTS13水平呈负相关(r=-0.457,P<0.001);多因素Logistic回归模型分析结果显示,高脂血症、骨折至开始手术时间长、血清sCD40L水平升高是老年髋部骨折患者术后发生下肢DVT的危险因素(P<0.05);血清ADAMTS13水平升高是影响老年髋部骨折患者术后发生下肢DVT的保护因素(P<0.05)。血清sCD40L、ADAMTS13联合预测老年髋部骨折患者术后发生下肢DVT的曲线下面积为0.812,大于sCD40L和ADAMTS13单独预测(P<0.05)。结论 老年髋部骨折术后发生下肢DVT患者血清sCD40L水平升高,ADAMTS13水平降低,二者水平可反映DVT的发生风险,且对老年髋部骨折患者发生下肢DVT具有一定的预测价值。 展开更多
关键词 可溶性细胞表面分化抗原40配体 血管性血友病因子裂解蛋白酶13 髋部骨折 下肢深静脉血栓
下载PDF
Interleukin-13 inhibits cytokines synthesis by blocking nuclear factor-κB and c-Jun N-terminal kinase in human mesangial cells 被引量:2
10
作者 Chunhua Zhu Aihua Zhang +3 位作者 Songming Huang GuixiaDing Xiaoqin Pan Ronghua Chen 《The Journal of Biomedical Research》 CAS 2010年第4期308-316,共9页
Objective: Monocytes/macrophages, proinflammatory cytokines and chemokines are important in the pathogenesis of glomerulonephritis. Interleukin (IL) -13 has been shown to exert potent anti-inflammatory properties. ... Objective: Monocytes/macrophages, proinflammatory cytokines and chemokines are important in the pathogenesis of glomerulonephritis. Interleukin (IL) -13 has been shown to exert potent anti-inflammatory properties. This study was designed to investigate the effect of IL-13 on the expression of proinflammatory cytokines, chemokines and profibrogenic cytokines and the involved molecular mechanism in cultured human mesangial cells (HMCs). Methods: The expressions of proinflammatory cytokines, chemokines and profibrogenic cytokines were determined by ribonuclease protection assay (RPA). Activity of nuclear factor-kappa B (NF-κB) and activa- tor protein-1 (AP-1) was examined by electrophoretic mobility shift assay (EMSA). NF-κB subunit p65 nuclear transportation and c-Jun N-terminal kinase (JNK) activity were assayed by immunoblot. Results: Recombinant IL-13 inhibited tumor necrosis factor-α (TNF-u), IL-1α, IL-1β, monocyte chemoattractant protein-1 (MCP-1), IL-8, and transforming growth factor-β1 (TGF-β1) mRNA expressions in a dose-dependent manner. Lipopoly- sacchorides (LPS) dramatically increased NF-κB DNA binding activity of HMCs, which was inhibited by IL-13 in a dose-dependent manner. LPS-activated NF-κB contained p50 and p65 dimers, but not c-Rel subunit. IL-13 blocked LPS-induced NF-κB subunit p65. LPS stimulated JNK/AP-1 activation, which was inhibited by IL-13 in a dose-dependent manner. Conclusion: IL-13 inhibits proinflammatory cytokines, chemokines, and profibrogenic cytokines synthesis by blocking NF-κB and JNK/AP-1 activation. These observations point to the importance of IL-13 in the modulation of inflammatory processes in the renal glomerulus. 展开更多
关键词 mesangial cells INTERLEUKIN-13 INFLAMMATION
下载PDF
shRNA沉默IGF-Ⅱ基因对人肾上腺皮质癌细胞株SW-13增殖与凋亡的影响
11
作者 杨翠英 罗佐杰 《山东医药》 CAS 2012年第33期1-4,14,共5页
目的探讨shRNA沉默IGF-Ⅱ基因对人肾上腺皮质癌细胞株SW-13增殖与凋亡的影响。方法构建针对人IGF-Ⅱ基因的shRNA慢病毒表达载体,稳定转染人肾上腺皮质癌细胞株SW-13。将实验随机分为3组:空白对照组、阴性对照组、IGF-Ⅱ-shRNA组,应用RT-... 目的探讨shRNA沉默IGF-Ⅱ基因对人肾上腺皮质癌细胞株SW-13增殖与凋亡的影响。方法构建针对人IGF-Ⅱ基因的shRNA慢病毒表达载体,稳定转染人肾上腺皮质癌细胞株SW-13。将实验随机分为3组:空白对照组、阴性对照组、IGF-Ⅱ-shRNA组,应用RT-PCR检测转染后各组IGF-Ⅱ基因mRNA的表达,以MTT比色法、流式细胞术检测转染后SW-13细胞生长增殖、凋亡的情况。结果 IGF-Ⅱ-shRNA组的IGF-Ⅱ基因mRNA表达量明显低于阴性对照组和空白对照组(P均<0.01),IGF-Ⅱ-shRNA组较之其他两组能明显抑制细胞的增殖(P均<0.01),IGF-Ⅱ-shRNA组的细胞凋亡率与其他两组相比显著增加(P均<0.01)。结论靶向IGF-Ⅱ基因的shR-NA可以有效抑制人肾上腺皮质癌细胞株SW-13的生长,并促进其凋亡,IGF-Ⅱ基因可能是肾上腺皮质癌治疗的一个潜在靶点。 展开更多
关键词 肾上腺质皮肿瘤 干扰素类 sw-13 细胞增殖 细胞凋亡
下载PDF
Construction of eukaryotic expression vector of human S100A13 gene and its effect on proliferation of human thyroid cancer cell line TT 被引量:1
12
作者 Xue-hui Xu Ren-xian Cao +2 位作者 Ying-lan Liu Jing Zhong Ge-bo Wen 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第3期321-329,共9页
Objective To investigate the effect of exogenous S100A13 gene overexpression on the proliferation of human thyroid cancer cell line TT.Methods The recombinant ORF of S100A13 tagged with six histidines at the 5' en... Objective To investigate the effect of exogenous S100A13 gene overexpression on the proliferation of human thyroid cancer cell line TT.Methods The recombinant ORF of S100A13 tagged with six histidines at the 5' end was subcloned into the pcDNA3.2/V5/GW/D-TOPO vector and sequenced.The eukaryotic expression plasmid pcDNA3.2/V5 /GW/D-S100A13 and empty vector pcDNA3.2/V5/GW/D were transfected into TT cells.The positive clones were selected by G418.The expressions of S100A13 mRNA and protein were detected by real time reverse transcription-polymerase chain reaction(RT-PCR) and Western blot.The effect of S100A13 on cell proliferation and cell cycle was evaluated by cell growth curve,MTT colorimetric assay and flow cytometry.Results S100A13 gene tagged with six histidines at the 5 ' end was confirmed to be inserted into the pcDNA3.2/V5/GW/D vector correctly.TT-S100A13-V5 cells,which over-expressed S100A13,were constructed successfully.TT-S100A13-V5 cells grew much faster than TT-V5 and TT cells(P <0.001).The proportions of both S and G2/M phase cells were significantly higher in TT-S100A13-V5 cells than those in TT-V5 and TT cells(P <0.001).Conclusion The eukaryotic expression vector containing human S100A13 gene has been successfully constructed,which highly expresses S100A13 in TT cells.Exogenous S100A13 gene overexpression accelerates TT cell proliferation and drives the cell cycle progression of TT cells from G0/G1 phase to S and G2/M phases. 展开更多
关键词 S100A13 gene TT cells gene transfection cell proliferation cell cycle
下载PDF
IL-13Ra2-and glioma stem cell-pulsed dendritic cells induce glioma cell death in vitro 被引量:3
13
作者 Ying Wang Ruifan Xie +1 位作者 Hongquan Niu Ting Lei 《Oncology and Translational Medicine》 2016年第5期210-215,共6页
Objective Gliomas are the most common malignant tumors in the central nervous system.Despite multiple therapies including surgery,chemotherapy,and radiotherapy,the prognosis of patients remains poor.Immunotherapy is a... Objective Gliomas are the most common malignant tumors in the central nervous system.Despite multiple therapies including surgery,chemotherapy,and radiotherapy,the prognosis of patients remains poor.Immunotherapy is an alternative method of treating glioma,and the use of dendritic cell vaccines is one of the promising treatment options.However,there is no specific tumor cell antigen that can trigger dendritic cells(DCs).IL-13Ra2 is a specific antigen expressed in glioma cells;in the current study,we have attempted to explore whether IL-13Ra2 could be the antigen that triggers DCs and to envisage its application as potential therapy for glioma.Methods The expression of IL-13Ra2 was detected in U251 glioma cell lines and primary glioma tissues using different methods.DCs from human blood were isolated and pulsed with recombinant IL-13Ra2,following which the cytotoxicity of these DCs on glioma cells was detected and analyzed.Results About 55.9% human glioma tissue cells expressed IL-13Ra2,while normal brain tissue cells did not show any expression.DC vaccines loaded with IL-13Ra2,glioma cell antigen,and brain tumor stem cell(BTSC) antigen could significantly stimulate the proliferation of T lymphocytes and induce cell death in the glioma tissue.Compared to other groups,DC vaccines loaded with BTSC antigen showed the strongest ability to activate cytotoxic T lymphocytes(CTLs),while the glioma cell antigen group showed no significant difference.Conclusion IL-13Ra2,which is expressed in gliomas and by glioma stem cells,as well as IL-13Ra2 could prove to be potential antigens for DC vaccine-based immunotherapy. 展开更多
关键词 dendritic cell brain tumor stem cell IL-13Ra2 GLIOMA
下载PDF
STR分型法鉴定人SW-13、293T及AGS细胞系种内及种间污染
14
作者 刘国娟 蔡伟文 +1 位作者 林峻 陈鲤群 《临床医学研究与实践》 2017年第10期1-4,共4页
目的检测研究所使用的人肾上腺皮质癌细胞SW-13、人胚肾细胞293T及人胃癌细胞AGS 3种细胞系污染情况,并探索短串联重复序列(short tandem repeat,STR)分型方法检测人类细胞系污染的可靠性。方法人类基因组上的微卫星位点携带着大量STR,... 目的检测研究所使用的人肾上腺皮质癌细胞SW-13、人胚肾细胞293T及人胃癌细胞AGS 3种细胞系污染情况,并探索短串联重复序列(short tandem repeat,STR)分型方法检测人类细胞系污染的可靠性。方法人类基因组上的微卫星位点携带着大量STR,每个STR核心序列的重复次数随个体不同存在差异,作为一种DNA标记使得细胞系在DNA水平上具有个性化。通过荧光聚合酶链式反应体系扩增STR位点,检测的数据与DSMZ细胞库进行匹配以对细胞系进行鉴别。结果比对得出SW-13基本匹配,其中20个STR基因位点中只有TH01位点的两个等位基因重复数为7和8,与DSMZ细胞库中此等位基因重复数7和7有差异,其余均一致在可接受范围内。细胞系293T、AGS等位基因的重复数与DSMZ细胞库完全匹配。结论 STR分型检测方法被ATCC、DSMZ等权威机构推崇,且此研究采用20位点检测法涵盖ATCC-9位点及中检院-16位点检测法,该法权威可靠。本所3种细胞系遗传稳定,均无种内或种间污染。 展开更多
关键词 STR分型 sw-13、293T及AGS 细胞系交叉污染
下载PDF
Tinospora crispa extract inhibits MMP-13 and migration of head and neck squamous cell carcinoma cell lines
15
作者 Hataipan Phienwej Ih-si Swasdichira +2 位作者 Surattana Amnuoypol Prasit Pavasant Piyamas Sumrejkanchanakij 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2015年第9期713-717,共5页
Objective: To investigate the effect of Tinospora crispa(T. crispa) extract on matrix metalloproteinase 13(MMP-13) expression and cell migration. Methods: The cytotoxicity of T. crispa extract was examined by 3-(4,5-d... Objective: To investigate the effect of Tinospora crispa(T. crispa) extract on matrix metalloproteinase 13(MMP-13) expression and cell migration. Methods: The cytotoxicity of T. crispa extract was examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay on head and neck squamous cell carcinoma(HNSCC) cell lines. The effect on expression of MMP-13 was analysed by RT-PCR and ELISA. The migration was assessed by wound healing assay. Results: MMP-13 m RNA was highly expressed in the metastatic human HNSCC cell lines, HN22 and HSC-3. T. crispa extract at a concentration of 100.0 μg/m L caused about 50% reduction of cell survival. T. crispa extract at a non-toxic concentration of 12.5, 25.0 and 50.0 μg/m L signii cantly suppressed MMP-13 m RNA expression and secreted MMP-13 in both HN22 and HSC-3. The expression of tissue inhibitors of metalloprotease by HSC-3 cells was attenuated by 25.0 and 50.0 μg/m L of T. crispa extract. Addition of the extract to cells in a wound healing assay showed inhibition of cell migration by HN22 cells. Conclusions: These data suggest that T. crispa could be considered as a potential therapeutic drug to prevent metastasis of HNSCC. 展开更多
关键词 Tinospora crispa Matrix METALLOPROTEINASE 13 cell MIGRATION SQUAMOUS cell carcinoma cell line PHYTOCHEMICAL
下载PDF
Glycosylation-independent binding to extracellular domains 11-13 of mannose-6-phosphate/insulin-like growth factor-2 receptor mediates the effects of soluble CREG on the phenotypic proliferation of vascular smooth muscle cells 被引量:5
16
作者 LUAN Bo~1,HAN Ya-ling~1,SUN Ming-yu~1,GUO Liang~1,GUO Peng~1,TAO Jie~1,DENG Jie~1,WU Guang-zhe~1,YAN Cheng-hui~1, LI Shao-hua~2 (1.Department of Cardiology,Shenyang Northern Hospital, Shenyang,China 2.Division of Vascular Surgery,Robert Wood Johnson Medical School-UMDNJ,New Jersey,USA) 《岭南心血管病杂志》 2011年第S1期186-186,共1页
Background The present study aimed to investigate the detailed mode and specific sites for their binding as well as the functional relevance of this binding in the phenotypic proliferation of vascular smooth muscle ce... Background The present study aimed to investigate the detailed mode and specific sites for their binding as well as the functional relevance of this binding in the phenotypic proliferation of vascular smooth muscle cells(SMCs). Methods CREG knocked-down SMCs were employed to evaluate the biological activity of wtCREG and mCREG.Expressions of SMC differentiation markers SM myosin heavy chain(SM-MHC),SM-actin,heavy caldesmon and myocardin were determined by Western blotting using specific antibodies. Cellular growth of SMCs was assessed by bromide dewuridine (BrdU) incorporation and cell cycle analysis on fluorescence-activated cell sorting(FACS).A solid-phase binding assay was used to study the binding of CREG to extracellular domains of M6P/IGF2R.The cellular co-localization of the two recombinant CREGs with M6P/IGF2R was detected on SMC surface by immunoprecipitation and immunofluorescence analysis.Results The molecular weight of wtCREG was around 30 kD while that of the mCREG was~25 kD.Treatment of wtCREG with PNGase F reduced its molecular weight from~30 kD to~25 kD,whereas PNGase F treatment had no effect on the molecular weight of mCREG.Both wtCREG and mCREG proteins enhanced SMC differentiation,inhibited BrdU incorporation,and arrested cell cycle progression when added to the culture medium.In CREG knocked-down SMCs,the amount of CREG detected by immunoblotting in M6P/IGF2R immunoprecipitates was significantly reduced when compared to normal cells.Both recombinant CREGs co-immunoprecipitated with M6P/IGF2R, although slightly reduced amount of the mutant CREG was detected in M6P/IGF2R immunoprecipitates.Immunostaining revealed that His-tagged CREGs co-localized with IGF2R on the cell surface in a glycosylation-independent manner.In vitro binding assay showed that CREGs bound to M6P/ IGF2R extracellular domains 7-10 and 11-13 in a glycosylation -dependent and -independent manner,respectively.Further blocking experiments using soluble M6P/IGF2R fragments and M6P/IGF2R neutralizing antibody indicated that the biological activities of recombinant CREGs in SMC growth and the up-regulation of SMC differentiation markers were all abolished by treatment with the M6P/IGF2R neutralizing antibody. However,although the growth inhibitory effect of wtCREG was nearly abolished by D7-10 or D11-13,the effect of mCREG was only reversed by Dll-13,indicating that the binding to domains 11-13 is required for CREG to modulate the proliferation of SMCs.Conclusions These data suggest that solubleCREG proteins can exert their biological function via binding to the extracellular domains 7-10 and 11-13 of cell surface M6P/IGF2R in both a glycosylation-dependent and -independent manner. 展开更多
关键词 CREG Glycosylation-independent binding to extracellular domains 11-13 of mannose-6-phosphate/insulin-like growth factor-2 receptor mediates the effects of soluble CREG on the phenotypic proliferation of vascular smooth muscle cells IGF
下载PDF
Regulation of mitochondrial carrier SLC25A13 on breast cancer cell cycle in vitro
17
作者 顾孝平 CHEN Meng-ping +3 位作者 LIANG A-juan LIU Yun-xia SUN Hai-peng 黄莹 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2019年第8期848-855,共8页
Objective·To investigate the role of mitochondrial solute carrier family 25 member 13(SLC25A13)on breast cancer development.Methods·SLC25A13 mRNA and protein expressions in invasive breast cancer tissues and... Objective·To investigate the role of mitochondrial solute carrier family 25 member 13(SLC25A13)on breast cancer development.Methods·SLC25A13 mRNA and protein expressions in invasive breast cancer tissues and normal breast tissues were from The Cancer Genome Atlas(TCGA)breast cancer dataset.Survival analysis was conducted online by Kaplan-Meier software.MCF-7 cell line was used for in vitro cell assay.Knockdown of SLC25A13 and sirtuin 2(SIRT2)were conducted by siRNA transfection.Cell viability was measured with trypan blue exclusion.Cell cycle arrest was determined by flow cytometry.The mRNA expression of SLC25A13 and P27 were detected by quantitative PCR.The protein level of SLC25A13,P27 and SIRT2 were detected by Western blotting.Protein half-life of P27 was assessed by Western blotting after cycloheximide treatment.Results·SLC25A13 was up-regulated in invasive breast cancer tissues.High expression of SLC25A13 correlated with poor overall survival and breast cancer recurrence.SLC25A13 knockdown inhibited MCF-7 cell cycle progression.P27 and SIRT2 both accumulated after SLC25A13 knockdown.P27 accumulation resulted from prolonged protein half-life.Knockdown of SIRT2 restored cell cycle arrest as well as P27 accumulation caused by SLC25A13 silencing.Conclusion·High expression of SLC25A13 may promote cell cycle progression via SIRT2 in breast cancer development. 展开更多
关键词 SOLUTE carrier family 25 MEMBER 13(SLC25A13) sirtuin-2(SIRT2) P27 BREAST cancer cell cycle
下载PDF
ILC2和MDSC及其相关细胞因子IL-13和iNOS在宫颈癌中的表达及其列线图模型的构建和评价
18
作者 王碧辉 朱玥洁 +3 位作者 张玉莲 吴雨峰 丁剑冰 陈志芳 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2024年第9期878-887,共10页
目的:研究2型固有淋巴样细胞(ILC2)和髓源性抑制细胞(MDSC)及其相关细胞因子IL-13和诱导型一氧化氮合酶(iNOS)在宫颈癌(CC)中的表达,并基于其构建CC发病风险的列线图预测模型。方法:采集2022年5月至2024年1月在新疆医科大学第一附属医... 目的:研究2型固有淋巴样细胞(ILC2)和髓源性抑制细胞(MDSC)及其相关细胞因子IL-13和诱导型一氧化氮合酶(iNOS)在宫颈癌(CC)中的表达,并基于其构建CC发病风险的列线图预测模型。方法:采集2022年5月至2024年1月在新疆医科大学第一附属医院手术切除的40例CC组织及100例外周血作为CC组,选取同期收治的30例子宫肌瘤经CC筛查为阴性的宫颈组织和100例正常健康个体外周血作为对照组。用多重免疫荧光技术(mIF)及免疫组化染色(IHC)法检测两组组织中ILC2和MDSC细胞浸润及其相关细胞因IL-13和iNOS的表达;使用流式细胞术和ELISA技术分别检测两组外周血中ILC2和MDSC及IL-13和iNOS的表达差异;通过Person相关性分析评估其相关性;使用单因素和多因素Logistic分析来确定ILC2和MDSC及IL-13和iNOS是否为CC发病的独立危险因素,再利用R软件建立免疫预测模型,使用ROC曲线下面积(AUC值)、Hosmer-Lemeshow检验、校准曲线、临床决策曲线和临床影响曲线来分别评估模型。结果:CC组中ILC2及MDSC及其相关细胞因子IL-13和iNOS均高于对照组(均P<0.05),且其均呈正相关(均P<0.05);经过单因素及多因素Logistic回归分析显示,ILC2、MDSC及IL-13、iNOS均是CC发病的独立危险因素(均P<0.05);基于这些危险因素的CC发病列线图,经过验证提示,该列线图模型具有一定的临床实用价值。结论:ILC2和MDSC及其相关的细胞因子IL-13和iNOS在CC组织及外周血中均呈高表达,基于这些危险因素构建的预测模型具有良好的预测能力和一定的实用性,为CC的早期诊断和治疗提供了一种简便有效的辅助工具。 展开更多
关键词 宫颈癌 2型固有淋巴样细胞 髓源性抑制细胞 白细胞介素13 诱导型一氧化氮合酶 列线图模型 诊断
下载PDF
Two potentially specific but relevant patterns of proteomic change Response of SH-SY5Y cells to differentiation with retinoic acid followed by phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate, and susceptibility of differentiated cells to dopamine
19
作者 Mingxiu Tian Xing'an Li +4 位作者 Ming Chang Yingjiu Zhang Danping Wang Hongrong Xie Linsen Hu 《Neural Regeneration Research》 SCIE CAS CSCD 2010年第20期1525-1533,共9页
Dopamine (DA) exposure at a dose of 100 pmol/L for 24 hours causes oxidative stress in SH-SY5Y cells with induction of neuronal differentiation by retinoic acid (RA,10 pmol/L,72 hours) followed by phorbol ester 12... Dopamine (DA) exposure at a dose of 100 pmol/L for 24 hours causes oxidative stress in SH-SY5Y cells with induction of neuronal differentiation by retinoic acid (RA,10 pmol/L,72 hours) followed by phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA,80 nmol/L,72 hours). However,it remains unclear whether the alteration of phenotype observed in response to oxidative stress is associated with protein regulation in this cellular model for Parkinson's disease. The present study detected protein regulation affected by oxidative stress at a proteomic level:selection of differentially altered proteins using two dimensional difference in-gel electrophoresis and identification of these proteins using matrix assisted laser desorption/ionization time-of-flight mass spectrometry. The results demonstrated significant alterations in expression of six proteins in SH-SY5Y cells following the differentiation and fourteen proteins in the differentiated cells following the exposure,exemplified by an increase of tubulin alpha1 in the former but a decrease of tubulin alpha-ubiquitous chain in the latter. These results suggest that two potentially specific but relevant patterns of proteomic change may be produced in SH-SY5Y cells with the induction of differentiation by RA followed by TPA,and in the differentiated cells after DA exposure. 展开更多
关键词 SH-SY5Y cells retinoic acid phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate DOPAMINE proteomic analysis Parkinson's disease neural regeneration
下载PDF
Replication of M13 single-stranded DNA bearing a sitespecific ethenocytosine lesion by Escherichia coil cell extracts
20
作者 WANGGE PAULMDUNMAN MZAFRIHUMAYUN 《Cell Research》 SCIE CAS CSCD 1997年第1期1-12,共12页
Previous investigation on the mutagenic effects of 3,N4-Ethenocytosine (εC), a nonpairing DNA lesion,revealed the existence of a novel SOS-independent inducible mutagenic mechanism in E. coli termed UVM for UV modula... Previous investigation on the mutagenic effects of 3,N4-Ethenocytosine (εC), a nonpairing DNA lesion,revealed the existence of a novel SOS-independent inducible mutagenic mechanism in E. coli termed UVM for UV modulation of mutagenesis. To investigate whether UVM is mediated by an alteration of DNA replication, we have set up an in vitro replication system ill which phage M13 viral single-stranded DNA bearing a single site-specific (εC) residue is replicated by soluble protein extracts from E. coli cells. Replication products were analyzed by agarose gel electrophoresis and the frequency of translesion synthesis was determined by restriction endonuclease analyses. Our data indicate that DNA replication is strongly inhibited by εC, but that translesion DNA synthesis does occur in about 14% of the replicated DNA molecules. These results are very similar to those observed previously in vivo, and suggest that this experimental system may be suitable for evaluating alterations in DNA replication in UVM-induced cells. 展开更多
关键词 Ethenocytosine M13 in vitro replication cell extract
下载PDF
上一页 1 2 23 下一页 到第
使用帮助 返回顶部